Uteroglobulin-related protein 1 and severity of respiratory syncytial virus infection in children admitted to hospital

✍ Scribed by Koichi Hashimoto; Masahiko Katayose; Hiroko Sakuma; Yukihiko Kawasaki; Makoto Sumikoshi; Hiroshi Sakata; Masatoki Sato; Shinichiro Ohara; Yusaku Abe; Masahiro Watanabe; Toshiko Sato; Kei Ishibashi; Tatsuo Suzutani; Mitsuru Munakata; Mitsuaki Hosoya

• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 94 KB
• Volume: 83
• Category: Article
• ISSN: 0146-6615
• DOI: 10.1002/jmv.22073

✦ Synopsis

Abstract

There are several reports suggesting that genetic factors contribute to the severity of infection with the respiratory syncytial virus (RSV). Infants hospitalized with lower respiratory tract infection (LRTI) due to RSV are at a significantly increased risk for both recurrent wheezing and childhood asthma. Uteroglobin‐related protein 1 (UGRP1) is a secretory protein expressed in the airways, and speculated to have anti‐inflammatory activity. The presence of the −112G/A polymorphism in the UGRP1 promoter was found to have a significant correlation with asthma phenotype. Also plasma UGRP1 levels were shown to be associated both with this polymorphism and the severity of asthma. The study population consisted of 62 previously healthy infants, ≤12 months of age, who were hospitalized with RSV LRTI, and a control group of 99 healthy adults. Genotyping was performed by restriction fragment length polymorphism. UGRP1 serum levels were determined using ELISA. There were no significant differences in the overall distribution of UGRP1 −112G/A polymorphism genotypes or alleles between the hospitalized infants and healthy adults. A comparison of serum UGRP1 concentration measured at the time of admission and discharge between patients with and without the −112A allele revealed that there was no relation between the presence of the −112A allele and serum UGRP1 in hospitalized infants with RSV infection. Furthermore, there was no relationship between severity of RSV infection and genotype or serum UGRP1 concentration. These results suggest that UGRP1 does not have a major role in the development of severe RSV infection. J. Med. Virol. 83:1086–1092, 2011. © 2011 Wiley‐Liss, Inc.